In The News
Why are so many people denied the painkillers they need?
The world is suffering from an invisible epidemic, an epidemic of pain. As many as 60 million people are reckoned to suffer avoidable agony every year.
The Feds Are Raiding the Offices of Doctors Who Prescribe Addiction Medication
Addiction doctors are worried about federal retribution against their treatment programs, and they're terrified for their patients, whose lives are at risk from overdose.
Extrajudicial Killings Surge in Bangladesh amid Fear of New Duterte-Style Drug War
At least 131 people have been publicly killed for alleged drug offences in Bangladesh in the past three weeks, with the country’s leaders lending their support to the approach.
ASEAN and HIV prevention amongst people who inject drugs: the need for an e ective and sustainable response Between 2010 and 2016, Asia and the Paci c registered one of the steepest declines in HIV infec ons globally, with prevalence rates dropping by approximately 13%. Despite this overall reduc on, HIV prevalence among people who inject drugs in Southeast Asia remains among the world’s highest.
Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries Current estimates suggest that 15% of all prisoners worldwide are chronically infected with the hepatitis C virus (HCV), and this number is even higher in regions with high rates of injecting drug use. Although harm reduction services such as opioid substitution therapy (OST) and needle and syringe programs (NSPs) are effective in preventing the further spread of HCV and HIV, the extent to which these are available in prisons varies significantly across countries.
The Global Fund Eligibility Policy and its impact on harm reduction funding The Global Fund to Fight AIDS, TB and Malaria is the largest funder of harm reduction globally, but its eligibility policy currently precludes certain Upper Middle Income Countries (UMICs) from applying for funding.